The combination of cetuximab and radiotherapy (CRT) has also been tested in several other EGFR-expressing squamous cell carcinomas including lung, anal, esophageal, and uterine cervix squamous cell carcinoma [15–18]. This evidence concerns the gene EGFR and squamous cell carcinoma.